Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic
##plugins.themes.bootstrap3.article.main##
Abstract
Introduction. Studies show that women with HIV have higher depression, anxiety symptoms and worse quality of life than men with HIV, but limited data on mental health status of people living with HIV (PLWH) is available in Mexico, hindering the development of specific mental health interventions.
Objective. To compare the frequency and severity of depression and anxiety symptoms between men and women of a HIV specialized clinic of Mexico City.
Method. Data were derived from a cross-sectional survey on condom use and serostatus disclosure carried out between 2012-2013. Data from Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and sociodemographic characteristics were included in this study. Non-parametric tests were used to compare sociodemographic, clinical and psychological variables and odds ratio were calculated.
Results. 291 PLWH were included, 13.1% (n = 38) were women. Significant differences between genders were found in sociodemographic variables (age, marital status, occupation, education, sexual orientation), but not in clinical variables. Depression symptoms were present in 45% of women versus 18.6% of men (x2 = 13.17, p < .001) and anxiety symptoms were present in 47.4% of women and 30% of men (x2 = 4.53, p = .033). In unadjusted analysis, women had 3.5 times higher risk than men of presenting depression symptoms (OR = 3.54, 95% CI = 1.61-7.65, p < .001) and 2 times higher risk of having anxiety symptoms than men (OR = 2.01, 95% CI = 0.98-4.42, p < .033).
Discussion and conclusion. An important percentage of participants had depression and anxiety symptoms; women showed greater frequency and severity of symptoms as well as greater socioeconomic vulnerability. Mental health interventions are needed and should take into consideration the gender specific differences.
References
Joint United Nations Programme on HIV/AIDS, UNAIDS. Estimaciones tomadas de la base de datos en línea AIDSinfo. In: Secretariat UNAIDS, ed. Switzerland, 2015.
Centro Nacional para la Prevención y el Control del VIH y el sida, CENSIDA. Informe nacional de avances en la respuesta al VIH y sida. Secretaría de Salud, 2015.
Secretaria de Salud, Dirección General de Epidemiología. Vigilancia Epidemiológica de casos de VIH/SIDA en México Registro Nacional de Casos de SIDA Actualización al Cierre de 2015. In: Centro Nacional para la prevención y el Control del VIH/SIDA CENSIDA, ed. México, 2016.
García-Sánchez I. Diferencias de género en el VIH/sida. Gaceta Sanitaria 2004;18:47-54.
Joint United Nations Programme on HIV/AIDS U. El VIH en las mujeres. 2012.
Bautista-Arredondo S, Servan-Mori E, Beynon F, González A, Volkow P. A tale of two epidemics: gender differences in socio-demographic characteristics and sexual behaviors among HIV positive individuals in Mexico City. Int J Equity Health 2015;14:1-10.
Logie CH, Newman PA, Weaver J, Roungkraphon S, Tepjan S. HIV-Related Stigma and HIV Prevention Uptake Among Young Men Who Have Sex with Men and Transgender Women in Thailand. AIDS Patient Care STDS 2016;30:92-100.
Brandt R. The mental health of people living with HIV/AIDS in Africa: a systematic review. Afr J AIDS Res: AJAR 2009;8:123-33.
Sherr L, Clucas C, Harding R, Sibley E, Catalan J. HIV and depression--a systematic review of interventions. Psychol Health Med 2011;16:493-527.
Parhami I, Fong TW, Siani A, Carlotti C, Khanlou H. Documentation of psychiatric disorders and related factors in a large sample population of HIV-positive patients in California. AIDS Behav 2013;17:2792-801.
Catalan J, Harding R, Sibley E, Clucas C, Croome N, Sherr L. HIV infection and mental health: suicidal behaviour--systematic review. Psychol Health Med 2011;16:588-611.
Tatum AK, Houston E. Examining the interplay between depression, motivation, and antiretroviral therapy adherence: a social cognitive approach. AIDS Care 2016:1-5.
Smith Fawzi MC, Ng L, Kanyanganzi F, et al. Mental Health and Antiretroviral Adherence Among Youth Living With HIV in Rwanda. Pediatrics 2016.
Safren SA, Bedoya CA, O'Cleirigh C, et al. Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial. Lancet HIV 2016.
Tao J, Qian HZ, Kipp AM, et al. Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed hiv-infected chinese men who have sex with men. AIDS (London, England) 2016.
Herkenham M, Kigar SL. Contributions of the adaptive immune system to mood regulation: Mechanisms and pathways of neuroimmune interactions. Prog Neuropsychopharmacol Biol Psychiatry 2016.
Amanor-Boadu S, Hipolito MS, Rai N, et al. Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans. World J Psychiatry 2016;6:128-35.
Caballero-Suárez NP, Rodríguez-Estrada E, Menez-Díaz JM, Safren SA, G. R-T, Riveros-Rosas A. Serostatus disclosure and condom use in people living with HIV: differences by type of partner. 28th International Congress of Applied Psychology: International Association of Applied Psychology; 2014.
Beck A, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventory-IA and -II in psychiatric outpatients. J Pers Assess 1996;67:588-97.
Jurado S, Villegas ME, Méndez L, Rodríguez F, Loperena V, Varela R. La estandarización del inventario de depresión de Beck para los residentes de la ciudad de México. Salud Mental 1998;21:26-31.
Rodriguez V, Magis C, Casillas J, et al. Internal consistency and factorial structure of the Beck Depression Inventory (BDI) in Mexican HIV-positive patients. In: Society IA, ed. XIX International AIDS Conference. Washington, D.C., USA.: International AIDS Society; 2012.
Beck A, Steer RA. Relationship between the Beck Anxiety Inventory and the Hamilton Anxiety Rating Scale with anxious outpatients. J Anxiety Disord 1991;5.
Robles R, Varela R, Jurado S, Páez F. Versión mexicana del Inventario de Ansiedad de Beck: propiedades psicométricas. Revista Mexicana de Psicología 2001;18: 211-7.
Salters KA, Irick M, Anema A, et al. Harder-to-reach people living with HIV experiencing high prevalence of all-type mental health disorder diagnosis. AIDS Care 2016:1-9.
Berger-Greenstein JA, Cuevas CA, Brady SM, Trezza G, Richardson MA, Keane TM. Major depression in patients with HIV/AIDS and substance abuse. AIDS patient care and STDs 2007;21:942-55.
Depression and HIV in the era of HAART. 2003. 2016, at http://www.thebody.com/content/art1819.html.)
Nogueira Campos L, De Fatima Bonolo P, Crosland Guimaraes MD. Anxiety and depression assessment prior to initiating antiretroviral treatment in Brazil. AIDS Care 2006;18:529-36.
C. WL, Alvarado MR, Wolff RM. Prevalencia, factores de riesgo y manejo de la depresión en pacientes con infección por
VIH: Revisión de la literatura. Revista chilena de infectología 2010;27:65-74.
Bayon C, Robertson K, Wolf E, et al. The prevalence of a positive screen for anxiety and/or depression in HIV-1 infected women across Western Europe and Canada- The CRANIum Study. 2nd International Workshop on HIV & Women. Bethesda, MD, USA2012.
Moore CL, Grulich AE, Prestage G, et al. Hospitalisation for Anxiety and Mood Disorders in HIV-infected and -Uninfected Gay and Bisexual Men. J Acquir Immune Defic Syndr (1999) 2016.
Saadat M, Behboodi ZM, Saadat E. Comparison of depression, anxiety, stress, and related factors among women and men with human immunodeficiency virus infection. J Hum Reprod Sci 2015;8:48-51.
Li J, Mo PKH, Kahler CW, et al. Prevalence and associated factors of depressive and anxiety symptoms among HIV-infected men who have sex with men in China. AIDS Care 2016;28:465-70.
Adams C, Zacharia S, Masters L, Coffey C, Catalan P. Mental health problems in people living with HIV: changes in the last two decades: the London experience 1990–2014. AIDS Care 2016;28:56-9.
